BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 19678577)

  • 1. Pancreatic cancer mortality in Serbia from 1991-2010 - a joinpoint analysis.
    Ilić M; Vlajinac H; Marinković J; Kocev N
    Croat Med J; 2013 Aug; 54(4):369-75. PubMed ID: 23986278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of health service amenable and non-amenable mortality before and since China's expansion of health coverage in 2009.
    Feng X; Liu Y; Astell-Burt T; Yin P; Page A; Liu S; Liu J; Wang L; Zhou M
    BMJ Open; 2016 Jan; 6(1):e009370. PubMed ID: 26733569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in oesophageal cancer mortality in Montenegro, 1990-2018.
    Nedović Vuković M; Jakšić M; Smolović B; Lukić M; Bukumirić Z
    Eur J Public Health; 2024 May; ():. PubMed ID: 38775329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RETRACTED: Cancer mortality trends in South Africa: 1997.
    Nhleko ML; Edoka I; Musenge E
    S Afr Med J; 2023 Aug; 113(8):33-36. PubMed ID: 37882118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different trends in stomach and pancreatic cancer mortality rates.
    Aragonés N; Parra-Blázquez D
    Rev Esp Enferm Dig; 2024 Jun; 116(6):299-301. PubMed ID: 38767009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Projection of the number of new oesophageal cancer cases in the world.
    Gatellier L; Charvat H
    Jpn J Clin Oncol; 2023 Aug; 53(9):870-871. PubMed ID: 37656657
    [No Abstract]   [Full Text] [Related]  

  • 7. Oesophageal cancer: risks, prevention, and diagnosis.
    BMJ; 2019 Sep; 366():l5391. PubMed ID: 31492677
    [No Abstract]   [Full Text] [Related]  

  • 8. ESPR 2023-Building new bridges from Belgrade.
    Lovrenski J; Pavićević P
    Pediatr Radiol; 2024 Apr; 54(4):479-480. PubMed ID: 38300285
    [No Abstract]   [Full Text] [Related]  

  • 9. Epidemiological trends in digestive cancers in Romania, 1955-2012, compared to alcohol consumption. Correlation or coincidence?
    Valean S; Chira R; Dumitrascu D
    Clujul Med; 2018 Oct; 91(4):376-386. PubMed ID: 30564012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting the Molecular Basis of Oesophageal Cancer for Targeted Therapies and Biomarkers for Drug Response: Guiding Clinical Decision-Making.
    Mbatha S; Hull R; Dlamini Z
    Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oesophageal-cancer-derived death in the population of Belgrade in a period 1989-2006].
    Janković J; Ratkov I; Sipetić S; Marinković J; Maksimović J
    Vojnosanit Pregl; 2009 Jul; 66(7):534-8. PubMed ID: 19678577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mortality from heart attack in Belgrade population during the period 1990-2004].
    Ratkov I; Sipetić S; Vlajinac H; Sekeres B
    Srp Arh Celok Lek; 2008; 136(11-12):598-602. PubMed ID: 19177820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality from stomach cancer in Serbia, excluding the province of Kosovo, in the 1991-2009 period.
    Ilic M; Prodovic T; Milosavljevic Z; Ljujic B
    Asian Pac J Cancer Prev; 2013; 14(3):2067-70. PubMed ID: 23679320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality rate of lip, oral cavity and pharynx malignant tumors in Serbia within a period 1991-2009.
    Ilić M; Radević S; Stefanović V; Cirković T; Zurovac T; Savić B; Kovacević V
    Vojnosanit Pregl; 2013 Feb; 70(2):189-94. PubMed ID: 23607187
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.